Chartwell Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-173,202
| Closed | -$8.82M | – | 445 |
|
|
2021
Q4 | $8.82M | Sell |
173,202
-3,260
| -2% | -$166K | 0.26% | 145 |
|
|
2021
Q3 | $9.84M | Sell |
176,462
-18,878
| -10% | -$1.05M | 0.31% | 125 |
|
|
2021
Q2 | $8.36M | Sell |
195,340
-2,063
| -1% | -$88.3K | 0.25% | 148 |
|
|
2021
Q1 | $8.24M | Buy |
197,403
+1,724
| +0.9% | +$72K | 0.25% | 154 |
|
|
2020
Q4 | $9.11M | Sell |
195,679
-2,490
| -1% | -$116K | 0.29% | 141 |
|
|
2020
Q3 | $8.42M | Sell |
198,169
-2,077
| -1% | -$88.2K | 0.31% | 129 |
|
|
2020
Q2 | $9.61M | Buy |
200,246
+8,662
| +5% | +$416K | 0.37% | 104 |
|
|
2020
Q1 | $8.81M | Buy |
191,584
+3,595
| +2% | +$165K | 0.41% | 89 |
|
|
2019
Q4 | $11.3M | Buy |
187,989
+1,300
| +0.7% | +$78.1K | 0.37% | 113 |
|
|
2019
Q3 | $10.6M | Sell |
186,689
-10,070
| -5% | -$570K | 0.35% | 112 |
|
|
2019
Q2 | $11M | Sell |
196,759
-10,025
| -5% | -$558K | 0.36% | 110 |
|
|
2019
Q1 | $10.4M | Sell |
206,784
-9,403
| -4% | -$475K | 0.34% | 114 |
|
|
2018
Q4 | $8.71M | Buy |
216,187
+60,578
| +39% | +$2.44M | 0.31% | 108 |
|
|
2018
Q3 | $10.8M | Sell |
155,609
-3,831
| -2% | -$266K | 0.32% | 112 |
|
|
2018
Q2 | $12.1M | Buy |
+159,440
| New | +$12.1M | 0.36% | 101 |
|
|
2017
Q1 | – | Sell |
-48,739
| Closed | -$3.87M | – | 448 |
|
|
2016
Q4 | $3.87M | Buy |
+48,739
| New | +$3.87M | 0.13% | 226 |
|